Patient Pathfinder: Clinical Trials
Clinical Trials for Lung Cancer
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 989 active Lung Cancer trials
Implementing Fragmentomics Into Real World Screening IntervenTions to Evaluate Clinical Utility Among Individuals With Elevated Risk for Lung Cancer
Study Type: Interventional
Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)
Study Type: Interventional Phase 3
Lung Cancer Screening Eligibility Assessment
Study Type: Interventional
Increasing Adherence to Lung Cancer Screening
Study Type: Interventional
Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer
Study Type: Interventional Phase 1
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
Study Type: Observational
A Study of V940 Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
Study Type: Interventional Phase 3
A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer
Study Type: Interventional Phase 1
There are 989 active Lung Cancer trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now